Furthermore, SIRT1 reduces age-related AF by blocking RIPK1 acetylation and by activating the SIRT1/PGC-1α/FNDC5 axis, it inhibits atrial fibrosis caused by angiotensin II (Ang II) (34). Here, FNDC5 is linked to atrial fibrillation.